{"id": "1335890559978749952", "creation": 1607336103.0, "user_id": "806947469951115264", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 1, "reply_count": 0, "like_count": 0, "quote_count": 0}}, "text": "#SerumInstitute Seeks #DCGI Approval For Emergency Use Authorisation Of #Covishield (#Oxford-#AstraZeneca #Vaccine) In #India\n#COVID19 #CovidVaccine #COVID19Vaccine #OxfordVaccine \nhttps://t.co/1gLFW3fSBw", "first_save": 1634559108.199414, "geo": "3f08724493b18d74", "hashtags": ["#SERUMINSTITUTE", "#DCGI", "#COVISHIELD", "#OXFORD", "#ASTRAZENECA", "#VACCINE", "#INDIA", "#COVID19", "#COVIDVACCINE", "#COVID19VACCINE", "#OXFORDVACCINE"]}